Cutter & CO Brokerage, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutter & CO Brokerage, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$575,108
+2.7%
37,176
+4.3%
0.17%
+1.8%
Q2 2023$559,913
-1.9%
35,641
+2.9%
0.16%
-7.3%
Q1 2023$570,811
+6.5%
34,637
+0.8%
0.18%
-1.7%
Q4 2022$535,945
+11.0%
34,355
-7.8%
0.18%
+0.6%
Q3 2022$483,000
-17.9%
37,275
-10.9%
0.18%
-10.4%
Q2 2022$588,000
+11.2%
41,856
+13.2%
0.20%
+28.0%
Q1 2022$529,000
+14.8%
36,966
+9.2%
0.16%
+24.6%
Q4 2021$461,000
-0.6%
33,851
+19.6%
0.13%
+13.5%
Q3 2021$464,00028,3000.11%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders